| Literature DB >> 34356043 |
Wenni You1, Mengjing Li1, Yilin Qi1, Yanbing Wang1, Yiwu Chen1, Ying Liu1, Li Li1, Hongsheng Ouyang1,2, Daxin Pang1,2.
Abstract
Many researchers have focused on knock-in pigs for site-specific integration, but little attention has been given to genetically modified pigs with the targeted integration of multiple recombinant genes. To establish a multigene targeted knock-in editing system, we used the internal ribosome entry site (IRES) and self-cleaving 2A peptide technology to construct a plasmid coexpressing the fatty acid desaturase (Fat-1) and porcine insulin-like growth factor-1 (IGF-1) genes at equal levels. In this study, pigs were genetically modified with multiple genes that were precisely inserted into the pRosa26 locus by using the clustered regularly spaced short palindrome repeat sequence (CRISPR)/CRISPR-related 9 (Cas9) system and somatic cell nuclear transfer technology (SCNT) in combination. Single copies of the Fat-1 and IGF-1 genes were expressed satisfactorily in various tissues of F0-generation pigs. Importantly, gas chromatography analysis revealed a significantly increased n-3 polyunsaturated fatty acid (PUFA) level in these genetically modified pigs, which led to a significant decrease of the n-6 PUFA/n-3 PUFA ratio from 6.982 to 3.122 (*** p < 0.001). In conclusion, the establishment of an editing system for targeted double-gene knock-in in this study provides a reference for the precise integration of multiple foreign genes and lays a foundation for the development of new transgenic pig breeds with multiple excellent phenotypes.Entities:
Keywords: CRISPR/Cas9; Fat-1; IGF-1; knock-in; pig
Mesh:
Substances:
Year: 2021 PMID: 34356043 PMCID: PMC8305104 DOI: 10.3390/genes12071027
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1IGF-1 and Fat-1 were integrated into pRosa26 locus by homologous recombination. (A) Schematic diagram of IRES-IGF1-2A-Fat1 inserted into the donor plasmid. (B) Strategy for the Cas9-mediated knock-in of IGF-1 and Fat-1 at pRosa26 site. (C) Schematic diagram of the Cas9/sgRNA plasmid. (D) The cleavage site of sgRNA at pRosa26 locus. (E) Screening of PFF clones by PCR with primer 1F/R. The primers 1F and 1R are designed in the upstream of 3’HA and downstream of 3’HA, respectively. M: DNA Marker III, WT: negative control. H2O: blank control. (F) Sanger sequencing of the products in (E). (G) RT-PCR was performed with primers 2F/R and 3F/R to confirm that the IGF-1 and Fat-1 genes were transcribed in the positive clones.
Figure 2Generation and genotype identification of F0 transgenic piglets. (A) Flow chart of the experimental procedures for preparing IGF-1 and Fat-1 knock-in pigs. (B) To assess blastocyst development in vitro, the reconstructed embryos were cultured to the blastocyst stage in vitro. (C) Photo of F0 three-day-old piglets with site-specific IGF-1 and Fat-1 gene knock-in. (D) PCR analysis of IGF-1 and Fat-1 knock-in pigs using the primers 1F/1R (mentioned above): M: DNA 2000, WT: negative control, H2O: blank control. (E) RT-PCR analysis of IGF-1 and Fat-1 positive pigs using the primers 2F/R and 3F/R, respectively.
Figure 3Expression analysis of the Fat-1 and IGF-1 genes. (A) Analyze the transcriptional expression of Fat-1 in different tissues by real-time PCR. The values are denoted as the mean ± SEM, n = 3, *** p < 0.001. (B) Analyze the transcriptional expression of IGF-1 in different tissues by real-time PCR.TG: transgenic pigs. WT: wild-type pigs. (C) Protein expression of IGF-1 in muscle tissue as determined by Western blot. (D) The n-6 PUFAs/n-3 PUFAs ratio in Fat-1 and IGF-1 knock-in pigs and WT. TG: transgenic pigs. WT: wild-type pigs.
Analysis of PUFAs in wild-type pigs and positive pigs (IGF-1 and Fat-1 knock-in).
| Fatty Acids | Positive Pigs | Wild-Type Pigs |
|---|---|---|
| n-3 PUFAs | ||
| C22:5(DPA) | 22.195 ± 0.064221 *** | 12.496 ± 0.053226 *** |
| C22:6(DHA) | 12.042 ± 0.041313 *** | 5.750 ± 0.038649 *** |
| C20:5(EPA) | 39.160 ± 0.48597 *** | 23.523 ± 0.002471 *** |
| C18:3(ALA) | 18.553 ± 0.09573 *** | 7.612 ± 0.021941 *** |
| Total n-3 | 91.951 ± 0.079628 *** | 49.381 ± 0.029869 *** |
| n-6 PUFAs | ||
| C18:2(LA) | 138.318 ± 0.034776 *** | 243.525 ± 0.066764 *** |
| C20:4(AA) | 148.747 ± 0.058109 *** | 101.243 ± 0.094351 *** |
| Total n-6 | 287.065 ± 0.010417 *** | 344.768 ± 0.080017 *** |
| n-6/n-3 ratio | 3.122 | 6.982 |
The data of each fatty acid in the table represents the percentage of this fatty acid to the total fatty acid. The values are denoted as the mean ± SEM, n = 3, *** p < 0.001.
Figure 4Analysis of off-target site. (A) The sequence and location of 10 potential off-target (OT) sites for sgRNA91/Cas9. (B) Cleavage analysis of 10 potential OT sites by T7E1. M: DNA 2000. (C) Sanger sequencing analysis of the PCR amplification products for 10 potential OT sites. The potential cleavage site of sgRNA91 has been marked with red arrow.